Cargando…
Effect of Hypoxia on DDR1 Expression in Pituitary Adenomas
BACKGROUND: Pituitary adenoma is a common intracranial tumor in neurosurgery. Some pituitary adenomas have the characteristics of invasive growth make them unable to be removed completely by surgery leading to easy relapse. Discoidin domain receptor l (DDR1) is a new kind of tyrosine kinase receptor...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
International Scientific Literature, Inc.
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4547544/ https://www.ncbi.nlm.nih.gov/pubmed/26286316 http://dx.doi.org/10.12659/MSM.894205 |
_version_ | 1782387081808445440 |
---|---|
author | Li, Shouchun Zhang, Zhiwen Xue, Jinghui Guo, Xiaoming Liang, Shuli Liu, Aijun |
author_facet | Li, Shouchun Zhang, Zhiwen Xue, Jinghui Guo, Xiaoming Liang, Shuli Liu, Aijun |
author_sort | Li, Shouchun |
collection | PubMed |
description | BACKGROUND: Pituitary adenoma is a common intracranial tumor in neurosurgery. Some pituitary adenomas have the characteristics of invasive growth make them unable to be removed completely by surgery leading to easy relapse. Discoidin domain receptor l (DDR1) is a new kind of tyrosine kinase receptor on the cell surface. DDR1 can be activated by tumor microenvironment signal in tumorigenesis, increasing MMP-2/9 expression and promoting the invasive ability of tumor cells. Anoxia can promote tumor growth and metastasis. This study investigated the impact of anoxic environment DDR1 expression in pituitary adenoma. MATERIAL/METHODS: A primary hypoxia pituitary adenoma cell model was established and treated with DDR1 inhibitor nilotinib. Real-time PCR and Western blot were used to detect DDR1 mRNA and protein expression. ELISA was used to detect MMP-2/9 changes. MTT method was used to detect pituitary adenoma cell proliferation. We used a transwell chamber to determine pituitary adenoma cell invasion ability. RESULTS: DDR1 mRNA and protein were significantly overexpressed under hypoxia (P<0.05). MMP-2 and MMP-9 expression was obviously increased in supernatant (P<0.05). Pituitary adenoma cell proliferation and invasive ability improved markedly under hypoxia (P<0.05). Nilotinib could reduce DDR1 expression, decrease MMP-2 and MMP-9 expression, and inhibit pituitary adenoma cells proliferation and invasion. CONCLUSIONS: Hypoxia can increase DDR1 expression in pituitary adenoma cells, leading to improved MMP-2 and MMP-9 secretion, and promoting pituitary adenoma cell proliferation and invasion. |
format | Online Article Text |
id | pubmed-4547544 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2015 |
publisher | International Scientific Literature, Inc. |
record_format | MEDLINE/PubMed |
spelling | pubmed-45475442015-09-02 Effect of Hypoxia on DDR1 Expression in Pituitary Adenomas Li, Shouchun Zhang, Zhiwen Xue, Jinghui Guo, Xiaoming Liang, Shuli Liu, Aijun Med Sci Monit Molecular Biology BACKGROUND: Pituitary adenoma is a common intracranial tumor in neurosurgery. Some pituitary adenomas have the characteristics of invasive growth make them unable to be removed completely by surgery leading to easy relapse. Discoidin domain receptor l (DDR1) is a new kind of tyrosine kinase receptor on the cell surface. DDR1 can be activated by tumor microenvironment signal in tumorigenesis, increasing MMP-2/9 expression and promoting the invasive ability of tumor cells. Anoxia can promote tumor growth and metastasis. This study investigated the impact of anoxic environment DDR1 expression in pituitary adenoma. MATERIAL/METHODS: A primary hypoxia pituitary adenoma cell model was established and treated with DDR1 inhibitor nilotinib. Real-time PCR and Western blot were used to detect DDR1 mRNA and protein expression. ELISA was used to detect MMP-2/9 changes. MTT method was used to detect pituitary adenoma cell proliferation. We used a transwell chamber to determine pituitary adenoma cell invasion ability. RESULTS: DDR1 mRNA and protein were significantly overexpressed under hypoxia (P<0.05). MMP-2 and MMP-9 expression was obviously increased in supernatant (P<0.05). Pituitary adenoma cell proliferation and invasive ability improved markedly under hypoxia (P<0.05). Nilotinib could reduce DDR1 expression, decrease MMP-2 and MMP-9 expression, and inhibit pituitary adenoma cells proliferation and invasion. CONCLUSIONS: Hypoxia can increase DDR1 expression in pituitary adenoma cells, leading to improved MMP-2 and MMP-9 secretion, and promoting pituitary adenoma cell proliferation and invasion. International Scientific Literature, Inc. 2015-08-19 /pmc/articles/PMC4547544/ /pubmed/26286316 http://dx.doi.org/10.12659/MSM.894205 Text en © Med Sci Monit, 2015 This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivs 3.0 Unported License |
spellingShingle | Molecular Biology Li, Shouchun Zhang, Zhiwen Xue, Jinghui Guo, Xiaoming Liang, Shuli Liu, Aijun Effect of Hypoxia on DDR1 Expression in Pituitary Adenomas |
title | Effect of Hypoxia on DDR1 Expression in Pituitary Adenomas |
title_full | Effect of Hypoxia on DDR1 Expression in Pituitary Adenomas |
title_fullStr | Effect of Hypoxia on DDR1 Expression in Pituitary Adenomas |
title_full_unstemmed | Effect of Hypoxia on DDR1 Expression in Pituitary Adenomas |
title_short | Effect of Hypoxia on DDR1 Expression in Pituitary Adenomas |
title_sort | effect of hypoxia on ddr1 expression in pituitary adenomas |
topic | Molecular Biology |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4547544/ https://www.ncbi.nlm.nih.gov/pubmed/26286316 http://dx.doi.org/10.12659/MSM.894205 |
work_keys_str_mv | AT lishouchun effectofhypoxiaonddr1expressioninpituitaryadenomas AT zhangzhiwen effectofhypoxiaonddr1expressioninpituitaryadenomas AT xuejinghui effectofhypoxiaonddr1expressioninpituitaryadenomas AT guoxiaoming effectofhypoxiaonddr1expressioninpituitaryadenomas AT liangshuli effectofhypoxiaonddr1expressioninpituitaryadenomas AT liuaijun effectofhypoxiaonddr1expressioninpituitaryadenomas |